Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII: Full Scheme Comparison and Current Status
- August 5, 2026
- Posted by: Kunal Singla
- Category: News
Nippon India Capital Builder Fund IV Series A last NAV Around Rs 10.33. UTI Long Term Advantage Fund Series VII NAV and AUM not publicly available for this specific option.
The Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison matters for investors who came across these two close ended equity schemes while researching older mutual fund NFOs and want to know where they stand today. Both funds were structured with a fixed tenure at launch but follow different investment themes. This Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII breakdown covers category, structure, available data and present day investability of each scheme.
Click Here – Get Free Investment Predictions
Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII: Quick Comparison at a Glance
This Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII table lays out the core facts side by side so you can see how the two close ended funds differ on structure, theme and scale.
| Parameter | Nippon India Capital Builder Fund IV Series A | UTI Long Term Advantage Fund Series VII |
|---|---|---|
| AMC | Nippon India Mutual Fund | UTI Mutual Fund |
| Category | Close Ended Equity, Multi Cap | Close ended equity linked savings scheme (elss) with a statutory lock in |
| Launch / Era | Launched 23 October 2017 | This series belongs to uti mutual fund’s close ended elss nfo family |
| Benchmark | Nifty 500 TRI (indicative for multi cap category) | Not confirmed in public trackers for this Series |
| Risk Level | Moderately High | Very High (typical for this category) |
| Last Available NAV | Around Rs 10.33 (Direct Growth, NAV as of October 2020) | Not publicly available for this specific option |
| AUM Last Reported | Approx Rs 145 Cr (Regular Plan, last reported) | Not publicly available for this specific option |
| Current Status | Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date | Close ended elss scheme subject to the standard tax saving lock in that applied at launch |
About Nippon India Capital Builder Fund IV Series A
In this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison, Nippon India Capital Builder Fund IV Series A is a close ended equity, multi cap scheme from Nippon India Mutual Fund. Launched 23 October 2017, benchmarked against the Nifty 500 TRI (indicative for multi cap category). Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date. That structure is the Kotak side of the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison.
About UTI Long Term Advantage Fund Series VII
The other half of this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison, UTI Long Term Advantage Fund Series VII, is a ELSS tax saving equity close ended equity linked savings scheme (ELSS) with a statutory lock in from UTI Mutual Fund. This series belongs to uti mutual fund’s close ended elss nfo family. Close ended elss scheme subject to the standard tax saving lock in that applied at launch. That is the UTI side of the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison.
Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII: Key Differences Explained
The points below summarise what the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison shows once you move past scheme names and into structure.
- Investment theme: Nippon India Capital Builder Fund IV Series A follows a close ended equity, multi cap mandate, while UTI Long Term Advantage Fund Series VII is built around ELSS tax saving equity, which is a different risk and return profile.
- AMC: Nippon India Capital Builder Fund IV Series A comes from Nippon India Mutual Fund, while UTI Long Term Advantage Fund Series VII comes from UTI Mutual Fund, so expense structures, fund management style and distribution reach differ.
- Structure: Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date By comparison, close ended ELSS scheme subject to the standard tax saving lock in that applied at launch
- Overall takeaway: the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison ultimately comes down to two different close ended strategies from different fund houses, and neither accepts fresh investment today.
These structural differences sit at the centre of any Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison and matter more than any single data point.
Check the Univest Screener for live fund and stock data
Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII: Are These Schemes Still Open for Fresh Investment
Both schemes in this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison were structured as close ended funds with a fixed tenure, which means neither accepts fresh lumpsum or SIP investment once the original NFO window closes. Investors who already hold units generally have to wait for maturity or a scheme merger to access their money. For Nippon India Capital Builder Fund IV Series A, close ended equity scheme launched october 2017; public nav tracking thins out after october 2020, consistent with scheme maturity on the fixed tenure date. For UTI Long Term Advantage Fund Series VII, close ended ELSS scheme subject to the standard tax saving lock in that applied at launch. Investors seeking similar exposure today can look at UTI Mutual Fund’s current open ended ELSS scheme, UTI Long Term Equity Fund, which is the practical takeaway from this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII status check.
Download the Univest iOS App or Univest Android App to track live NAV updates and screen mutual fund data on the go.
Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII: Which One Fits Your Portfolio
Since both schemes are close ended and not confirmed open for fresh investment, this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison is most useful for existing unit holders trying to understand their scheme’s positioning. This Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII guidance section exists for that reason. Investors who already hold either scheme should track maturity dates, merger announcements or IDCW payouts through their AMC’s official communication and consolidated account statements, since specific NAV and AUM for UTI Long Term Advantage Fund Series VII were not publicly available for this analysis. That is the core practical lesson of this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison, and it is always worth confirming details with a SEBI registered advisor before deciding.
Conclusion
The Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison shows two different close ended equity strategies, one from Nippon India Mutual Fund and the other from UTI Mutual Fund. Neither scheme is confirmed open for fresh investment today. This Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII review is a reminder to check AMC statements for the latest status on any holding. New investors exploring similar strategies should look at current open ended schemes from Nippon India Mutual Fund and UTI Mutual Fund and consult a SEBI registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII
The common questions readers ask about the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison are answered below.
Is Nippon India Capital Builder Fund IV Series A open for fresh investment right now?
Ans. No. In the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison, Nippon India Capital Builder Fund IV Series A is the close ended scheme from Nippon India Mutual Fund. Close ended equity scheme launched October 2017; public NAV tracking thins out after October 2020, consistent with scheme maturity on the fixed tenure date.
Is UTI Long Term Advantage Fund Series VII still open for investment today?
Ans. In the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison, UTI Long Term Advantage Fund Series VII is a close ended equity linked savings scheme (ELSS) with a statutory lock in. Close ended elss scheme subject to the standard tax saving lock in that applied at launch, so specific current NAV and AUM data are not publicly available.
What is the single biggest difference highlighted in the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison?
Ans. The biggest difference in the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison is investment theme. Nippon India Capital Builder Fund IV Series A follows a close ended equity, multi cap mandate, while UTI Long Term Advantage Fund Series VII is built around ELSS tax saving equity.
Which AMC manages each fund in this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison?
Ans. Nippon India Capital Builder Fund IV Series A is managed by Nippon India Mutual Fund, and UTI Long Term Advantage Fund Series VII is managed by UTI Mutual Fund.
What should existing investors take away from the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison?
Ans. Existing investors reading this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison should refer to their AMC statements and any maturity or merger notice for the current status of their holding.
Is there an open ended alternative to the schemes in this Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison?
Ans. For UTI Long Term Advantage Fund Series VII, investors can look at UTI Mutual Fund’s current open ended ELSS scheme, UTI Long Term Equity Fund. For Nippon India Capital Builder Fund IV Series A, Nippon India Mutual Fund offers other diversified equity schemes for investors seeking similar exposure today.
What risk category applies across the Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII comparison?
Ans. Nippon India Capital Builder Fund IV Series A is rated Moderately High risk. Close ended equity schemes like UTI Long Term Advantage Fund Series VII are typically also rated Very High risk.
This Nippon India Capital Builder Fund IV Series A vs UTI Long Term Advantage Fund Series VII summary is meant to be read alongside your own AMC statement for full accuracy.
